150 related articles for article (PubMed ID: 28467432)
1. Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.
Kuczkowska K; Myrbråten I; Øverland L; Eijsink VGH; Follmann F; Mathiesen G; Dietrich J
PLoS One; 2017; 12(5):e0176401. PubMed ID: 28467432
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.
Kuczkowska K; Kleiveland CR; Minic R; Moen LF; Øverland L; Tjåland R; Carlsen H; Lea T; Mathiesen G; Eijsink VGH
Appl Environ Microbiol; 2017 Jan; 83(2):. PubMed ID: 27815271
[TBL] [Abstract][Full Text] [Related]
3. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
[TBL] [Abstract][Full Text] [Related]
4. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted
Wern JE; Sorensen MR; Olsen AW; Andersen P; Follmann F
Front Immunol; 2017; 8():569. PubMed ID: 28567043
[TBL] [Abstract][Full Text] [Related]
7. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization.
Thakur A; Rodríguez-Rodríguez C; Saatchi K; Rose F; Esposito T; Nosrati Z; Andersen P; Christensen D; Häfeli UO; Foged C
Front Immunol; 2018; 9():2825. PubMed ID: 30555488
[TBL] [Abstract][Full Text] [Related]
8. Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming.
McEntee CP; Moran HBT; Muñoz-Wolf N; Liddicoat AM; Carroll EC; Erbo-Wern J; Coulter IS; Andersen P; Follmann F; Lavelle EC
Vaccine; 2020 Jan; 38(3):635-643. PubMed ID: 31727505
[TBL] [Abstract][Full Text] [Related]
9. Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis.
Lorenzen E; Follmann F; Bøje S; Erneholm K; Olsen AW; Agerholm JS; Jungersen G; Andersen P
Front Immunol; 2015; 6():628. PubMed ID: 26734002
[TBL] [Abstract][Full Text] [Related]
10. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
Yao XY; Yuan MM; Li DJ
Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
[TBL] [Abstract][Full Text] [Related]
11. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
12. A Liposome-Based Adjuvant Containing Two Delivery Systems with the Ability to Induce Mucosal Immunoglobulin A Following a Parenteral Immunization.
Christensen D; Bøllehuus Hansen L; Leboux R; Jiskoot W; Christensen JP; Andersen P; Dietrich J
ACS Nano; 2019 Feb; 13(2):1116-1126. PubMed ID: 30609354
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.
Xu YG; Guan XT; Liu ZM; Tian CY; Cui LC
Appl Environ Microbiol; 2015 Jun; 81(11):3745-52. PubMed ID: 25819954
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells.
Mobergslien A; Vasovic V; Mathiesen G; Fredriksen L; Westby P; Eijsink VG; Peng Q; Sioud M
Hum Vaccin Immunother; 2015; 11(11):2664-73. PubMed ID: 26185907
[TBL] [Abstract][Full Text] [Related]
15. Protection of pigs against genital Chlamydia trachomatis challenge by parenteral or mucosal DNA immunization.
Schautteet K; De Clercq E; Jönsson Y; Lagae S; Chiers K; Cox E; Vanrompay D
Vaccine; 2012 Apr; 30(18):2869-81. PubMed ID: 22387629
[TBL] [Abstract][Full Text] [Related]
16. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
[TBL] [Abstract][Full Text] [Related]
17. Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis.
Garcia-Del Rio L; Diaz-Rodriguez P; Pedersen GK; Christensen D; Landin M
Adv Healthc Mater; 2022 Jun; 11(11):e2102508. PubMed ID: 35124896
[TBL] [Abstract][Full Text] [Related]
18. Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease.
del Rio B; Dattwyler RJ; Aroso M; Neves V; Meirelles L; Seegers JF; Gomes-Solecki M
Clin Vaccine Immunol; 2008 Sep; 15(9):1429-35. PubMed ID: 18632920
[TBL] [Abstract][Full Text] [Related]
19. Multi-component prime-boost
Lorenzen E; Contreras V; Olsen AW; Andersen P; Desjardins D; Rosenkrands I; Juel HB; Delache B; Langlois S; Delaugerre C; Joubert C; Dereuddre-Bosquet N; Bébéar C; De Barbeyrac B; Touati A; McKay PF; Shattock RJ; Le Grand R; Follmann F; Dietrich J
Front Immunol; 2022; 13():1057375. PubMed ID: 36505459
[TBL] [Abstract][Full Text] [Related]
20. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
Rochereau N; Pavot V; Verrier B; Jospin F; Ensinas A; Genin C; Corthésy B; Paul S
J Allergy Clin Immunol; 2016 Jan; 137(1):214-222.e2. PubMed ID: 26414879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]